Abstract
Sequentially randomized designs are commonly used in biomedical research, particularly in clinical trials, to assess and compare the effects of different treatment regimes. In such designs, eligible patients are first randomized to one of the initial therapies, and then patients with some intermediate response (e.g., without progressive diseases) are randomized to one of the maintenance therapies. The goal is to evaluate dynamic treatment regimes consisting of an initial therapy, the intermediate response, and a maintenance therapy. In this article, we demonstrate the use of the pattern-mixture model (commonly used for analyzing missing data) for estimating the effects of treatment regimes based on familiar survival analysis techniques such as Nelson-Aalen and parametric models. Moreover, we demonstrate how to use estimates from pattern-mixture models to test for the differences across treatment regimes in a weighted log-rank setting. We investigate the properties of the proposed estimators and test in a Monte Carlo simulation study. Finally, we demonstrate the methods using the long-term survival data from the high-risk neuroblastoma study.
Similar content being viewed by others
References
Feng, W., and A. S. Wahed. 2008. Supremum weighted log-rank test and sample size for comparing two-stage adaptive treatment strategies, Biometrika, 95, 695–707.
Fleming T. R., and D. P. Harrington. 1991. Counting processes and survival analysis. New York, NY: John Wiley & Sons.
Guo, X., and A. A. Tsiatis. 2005. A weighted risk estimator for survival distributions in two-stage randomization designs with censored survival data. Int. J. Biostat., 1, 1–15.
Hernan, M. A., E. Lanoy, D. Costagliola, and J. M. Robins. 2006. Comparison of dynamic treatment regimes via inverse probability weighting. Basic Clin. Pharmacol. Toxicol., 98, 237–242.
Klein, J. P., and M. L. Moeschberger. 2003. Survival analysis techniques for censored and truncated data. New York, NY: Springer.
Little, R. J. A. 1993. Pattern-mixture models for multivariate incomplete data. J. Am. Stat. Assoc., 88, 125–134.
Lokhnygina, Y., and J. D. Helterbrand. 2007. Cox regression methods for two-stage randomization designs. Biometrics, 63, 422–428.
Lunceford, J. K., M. Davidian, and A. A. Tsiatis. 2002. Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials. Biometrics, 58, 48–57.
Matthay, K. K., J. G. Villablanca, R. C. Seeger, D. O. Stram, R. E. Harris, N. K. Ramsay, P. Swift, H. Shimada, C. T. Black, G. M. Brodeur, R. B. Gerbing, and C. P. Reynolds. 1999. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N. Engl. J. Med., 341, 1165–1173.
Matthay, K. K., C. P. Reynolds, R. C. Seeger, H. Shimada, E. S. Adkins, D. Haas-Kogan, R. B. Gerbing, W. B. London, and J. G. Villablanca. 2009. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: A Children’s Oncology Group study. J. Clin. Oncol., 27, 1007–1013.
Molenbergh, G., and M. G. Kenward. 2007. Missing data in clinical studies. Chichester, England: John Wiley & Sons Ltd.
Murphy, S. A. 2003. Optimal dynamic treatment regimes, J. R. Stat. Society Ser. B, 65, 331–355.
Murphy, S. A., and D. Bingham. 2009. Screening experiments for developing dynamic treatment regimes. J. Am. Stat. Assoc., 104, 391–409.
Murphy, S. A., M. J. van der Laan, and J. M. Robins. 2001. Marginal mean models for dynamic regimes. J. Am. Stat. Assoc., 96, 1410–1423.
Robins, J. M. 1986. A new approach to causal inference in mortality studies with sustained exposure periods-application to control of the healthy survivor effect. Math. Model., 7, 1393–1512.
Robins, J. M. 1987. Addendum to “A new approach to causal inference in mortality studies with sustained exposure periods-application to control of the healthy survivor effect” [Math Model 1986;7:1393-1512]. Computers Math. Appl., 14, 923–945.
Wahed, A. S., and A. A. Tsiatis. 2004. Optimal estimator for the survival distribution and related quantities for treatment policies in two-stage randomization designs in clinical trials. Biometrics, 60, 124–133.
Wahed, A. S., and A. A. Tsiatis. 2006. Semiparametric efficient estimation of survival distributions in two-stage randomization designs in clinical trials with censored data. Biometrika, 93, 163–177.
Author information
Authors and Affiliations
Corresponding author
Additional information
Color versions of one or more of the figures in the article can be found online at https://doi.org/www.tandfonline.com/ujsp.
Rights and permissions
About this article
Cite this article
Tang, X., Wahed, A.S. Pattern-Mixture-Type Estimation and Testing of Neuroblastoma Treatment Regimes. J Stat Theory Pract 9, 266–287 (2015). https://doi.org/10.1080/15598608.2013.878888
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1080/15598608.2013.878888